Cardiovascular Clinical Trials in Durham, North Carolina
16 recruitingDurham, North Carolina
Showing 1–16 of 16 trials
Recruiting
Phase 2Phase 3
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
Atherosclerotic Cardiovascular Disease
CSL Behring2,310 enrolled542 locationsNCT05485961
Recruiting
Phase 3
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Cardiovascular Disease
Amgen11,000 enrolled243 locationsNCT07136012
Recruiting
Phase 3
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
ObesityOverweightAtherosclerotic Cardiovascular Disease
Amgen12,800 enrolled759 locationsNCT07037433
Recruiting
Phase 3
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
HypertensionHigh Risk Cardiovascular DiseaseHigh Cardiovascular Risk
Alnylam Pharmaceuticals11,000 enrolled597 locationsNCT07181109
Recruiting
Phase 3
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Cardiovascular Disease
AstraZeneca15,100 enrolled1264 locationsNCT07000357
Recruiting
Product Surveillance Registry
Cardiac Rhythm DisordersNeurological DisordersCardiovascular Disorders+1 more
Medtronic100,000 enrolled391 locationsNCT01524276
Recruiting
Phase 3
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular RiskAcute Myocardial Infarction (AMI)
Novo Nordisk A/S10,000 enrolled970 locationsNCT06118281
Recruiting
Global Paradise System US Post Approval Study
Cardiovascular DiseasesHypertensionVascular Diseases
ReCor Medical, Inc.1,000 enrolled38 locationsNCT06297291
Recruiting
Not Applicable
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Heart FailureCardiovascular DiseasesHeart Diseases
BrioHealth Solutions, Inc.780 enrolled37 locationsNCT06310031
Recruiting
Phase 1
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
HypercholesterolaemiaMetabolic DiseaseDyslipidemias+7 more
CRISPR Therapeutics AG90 enrolled18 locationsNCT07491172
Recruiting
PKP2-ACM Natural History Study
CardiomyopathiesCardiovascular DiseasesHeart Diseases
Rocket Pharmaceuticals Inc.36 enrolled3 locationsNCT06644742
Recruiting
Not Applicable
Cardiac point-of Care Ultrasound Training Pathway for Emergency Department Advanced Practice Providers
Pulmonary Embolism (Diagnosis)Diagnostic ImagingImplementation Science+7 more
Duke University75 enrolled1 locationNCT07159269
Recruiting
Not Applicable
Role of Aging and Individual Variation in Exercise Training Responsiveness
ObesityInsulin ResistanceCardiovascular Diseases+1 more
Duke University26 enrolled1 locationNCT06471569
Recruiting
Phase 4
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Cardiovascular DiseasesDementiaCognitive Impairment, Mild
Duke University20,000 enrolled103 locationsNCT04262206
Recruiting
Observational Pharmaco-Epidemiology Research & Analysis
Cardiovascular DiseasesInflammatory Bowel DiseasesLiver Diseases+4 more
Epividian2,000,000 enrolled1 locationNCT03813862
Recruiting
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
Acute Kidney InjuryIntraabdominal HypertensionAbdominal Compartment Syndrome+1 more
Potrero Medical2,500 enrolled9 locationsNCT04669548